Jane Street Group, LLC Macrogenics Inc Call Options Transaction History

Jane Street Group, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$3.0 - $5.55 $62,700 - $115,995	20,900 New	20,900 $68,000
Q1 2022 May 17, 2022	SELL	$8.12 - $16.9 $233,855 - $486,719	-28,800 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$15.91 - $21.88 $187,738 - $258,184	11,800 Added 69.41%	28,800 $462,000
Q3 2021 Nov 16, 2021	SELL	$19.74 - $28.7 $183,582 - $266,910	-9,300 Reduced 35.36%	17,000 $356,000
Q2 2021 Aug 16, 2021	BUY	$20.49 - $35.63 $10,245 - $17,815	500 Added 1.94%	26,300 $706,000
Q1 2021 May 18, 2021	BUY	$18.99 - $33.2 $123,434 - $215,800	6,500 Added 33.68%	25,800 $822,000
Q4 2020 Feb 17, 2021	SELL	$19.41 - $26.0 $135,870 - $182,000	-7,000 Reduced 26.62%	19,300 $441,000
Q3 2020 Nov 17, 2020	BUY	$24.69 - $31.6 $375,288 - $480,320	15,200 Added 136.94%	26,300 $662,000
Q2 2020 Aug 17, 2020	BUY	$5.2 - $29.12 $57,720 - $323,232	11,100 New	11,100 $310,000

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.